Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01946724 · ClinicalTrials.gov registry record
In-hospital and Long-term Outcomes for Percutaneous Chronic Total Coronary Occlusion Revascularization in a High-volume, Multi-operator Program
A clinical trial, sponsored by Piedmont Healthcare.
- Completed
- Registry status
- 500
- Enrollment target
NCT01946724: Completed study, sponsored by Piedmont Healthcare.
NCT01946724 is a clinical trial that has completed, run by Piedmont Healthcare. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01946724 has completed, sponsored by Piedmont Healthcare.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
The purpose of this study is to study whether percutaneous chronic total occlusion (CTO) revascularization, by the use of Percutaneous Coronary Intervention (PCI), stenting, guidewire, and catheter, improves a patient's quality of life and their left ventricular function, reduces angina severity, and improves long-term survival.
Primary Outcome
CTO procedural success as defined by an achievement of a final residual angiographic stenosis \< 50% within the treated segment with \>=TIMI 2 antegrade flow.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2013-08 |
| Est. Completion | 2017-05-24 |
What the finished NCT01946724 record still lists
NCT01946724 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01946724 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01946724 about?
NCT01946724 is a clinical study titled "In-hospital and Long-term Outcomes for Percutaneous Chronic Total Coronary Occlusion Revascularization in a High-volume, Multi-operator Program". The purpose of this study is to study whether percutaneous chronic total occlusion (CTO) revascularization, by the use of Percutaneous Coronary Intervention (PCI), stenting, guidewire, and catheter, improves a patient's quality of life and their left ventricular function, reduces angina severity, an...
What is the current status of trial NCT01946724?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2013-08. Estimated completion is 2017-05-24.
Who is sponsoring clinical trial NCT01946724?
This trial is sponsored by Piedmont Healthcare, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia